Skip to content

Identifing the markers for chemotherapy - induced liver damage

Identifing the markers for chemotherapy - induced liver damage - Identifing the markers for chemotherapy - induced liver damage

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000008602
Enrollment
100
Registered
2012-08-02
Start date
2012-08-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver tumors

Interventions

Fibroscan Blood sample

Sponsors

Yokohama City University, Department of Gastroenterological Surgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Elective cases of liver resection

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Correlation between preoperative fibroscan data or melcaptal/nonmercaptal albumin and pathological liver damage

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026